Quantcast
Home > Quotes > BSGM

BioSig Technologies, Inc. Common Stock (BSGM) Quote & Summary Data

BSGM 
$3.72
*  
0.03
0.8%
Get BSGM Alerts
*Delayed - data as of Nov. 20, 2018  -  Find a broker to begin trading BSGM now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    BSGM After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 3.55 / $ 4.82
1 Year Target
11.875
Today's High / Low
$ 3.95 / $ 3.55
Share Volume
71,950
50 Day Avg. Daily Volume
N/A
Previous Close
$ 3.75
52 Week High / Low
$ 7.1309 / $ 3.50
Market Cap
55,569,200
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
71,950
50 Day Avg. Daily Volume:
N/A

Trading Range

The current last sale of $3.72 is 6.29% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 3.95 $ 7.1309
 Low: $ 3.55 $ 3.50

Company Description (as filed with the SEC)

We were formed as BioSig Technologies, Inc., a Nevada corporation, in February 2009 and in April 2011 we merged with our wholly-owned subsidiary, BioSig Technologies, Inc., a Delaware corporation, with the Delaware corporation continuing as the surviving entity. We are principally devoted to improving biomedical signal processing to extract information from physiologic signals. Our initial focus is on providing intracardiac signal information to electrophysiologists during electrophysiology (EP) studies and catheter ablation for complex arrhythmias, atrial fibrillation (AF) and ventricular tachycardia (VT). We have not generated any revenue to date and consequently our operations are subject to all risks inherent in the establishment of a new business enterprise. Business Overview We are a development stage medical device company developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals.  ... More ...  


Risk Grade

Where does BSGM fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 3.70
Open Date:
Nov. 20, 2018
Close Price:
$ 3.85
Close Date:
Nov. 19, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x